ENST00000606567.6:c.-386A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000606567.6(POU5F1):​c.-386A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0393 in 1,187,126 control chromosomes in the GnomAD database, including 1,760 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.073 ( 678 hom., cov: 32)
Exomes 𝑓: 0.034 ( 1082 hom. )

Consequence

POU5F1
ENST00000606567.6 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.253

Publications

2 publications found
Variant links:
Genes affected
POU5F1 (HGNC:9221): (POU class 5 homeobox 1) This gene encodes a transcription factor containing a POU homeodomain that plays a key role in embryonic development and stem cell pluripotency. Aberrant expression of this gene in adult tissues is associated with tumorigenesis. This gene can participate in a translocation with the Ewing's sarcoma gene on chromosome 21, which also leads to tumor formation. Alternative splicing, as well as usage of alternative AUG and non-AUG translation initiation codons, results in multiple isoforms. One of the AUG start codons is polymorphic in human populations. Related pseudogenes have been identified on chromosomes 1, 3, 8, 10, and 12. [provided by RefSeq, Oct 2013]
TCF19 (HGNC:11629): (transcription factor 19) This gene encodes a protein that contains a PHD-type zinc finger domain and likely functions as a transcription factor. The encoded protein plays a role proliferation and apoptosis of pancreatic beta cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU5F1NM_002701.6 linkc.406-767A>G intron_variant Intron 1 of 4 ENST00000259915.13 NP_002692.2 Q01860-1D2IYK3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU5F1ENST00000259915.13 linkc.406-767A>G intron_variant Intron 1 of 4 1 NM_002701.6 ENSP00000259915.7 Q01860-1

Frequencies

GnomAD3 genomes
AF:
0.0731
AC:
11121
AN:
152094
Hom.:
676
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0416
Gnomad ASJ
AF:
0.0444
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.0427
Gnomad FIN
AF:
0.0526
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0287
Gnomad OTH
AF:
0.0746
GnomAD4 exome
AF:
0.0343
AC:
35548
AN:
1034914
Hom.:
1082
Cov.:
31
AF XY:
0.0340
AC XY:
16666
AN XY:
489460
show subpopulations
African (AFR)
AF:
0.162
AC:
3498
AN:
21638
American (AMR)
AF:
0.0366
AC:
295
AN:
8060
Ashkenazi Jewish (ASJ)
AF:
0.0487
AC:
632
AN:
12978
East Asian (EAS)
AF:
0.177
AC:
3318
AN:
18694
South Asian (SAS)
AF:
0.0350
AC:
1462
AN:
41820
European-Finnish (FIN)
AF:
0.0590
AC:
348
AN:
5898
Middle Eastern (MID)
AF:
0.0387
AC:
99
AN:
2560
European-Non Finnish (NFE)
AF:
0.0270
AC:
23870
AN:
883188
Other (OTH)
AF:
0.0506
AC:
2026
AN:
40078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1590
3179
4769
6358
7948
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1238
2476
3714
4952
6190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0731
AC:
11131
AN:
152212
Hom.:
678
Cov.:
32
AF XY:
0.0740
AC XY:
5508
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.158
AC:
6562
AN:
41492
American (AMR)
AF:
0.0415
AC:
635
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0444
AC:
154
AN:
3472
East Asian (EAS)
AF:
0.167
AC:
867
AN:
5186
South Asian (SAS)
AF:
0.0427
AC:
206
AN:
4820
European-Finnish (FIN)
AF:
0.0526
AC:
558
AN:
10604
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0287
AC:
1954
AN:
68018
Other (OTH)
AF:
0.0753
AC:
159
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
499
999
1498
1998
2497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0522
Hom.:
619
Bravo
AF:
0.0784
Asia WGS
AF:
0.115
AC:
400
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
5.3
DANN
Benign
0.76
PhyloP100
0.25
PromoterAI
0.0030
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11965454; hg19: chr6-31134591; API